Article(id=1329914175750517551, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329914129239879905, articleNumber=null, orderNo=null, doi=10.13683/j.wph.2018.04.012, pmid=null, cstr=null, oa=null, hot=null, price=null, onlineType=0, articleFormat=0, articleType=null, articleTypeStr=null, receivedDate=1516204800000, receivedDateStr=2018-01-18, revisedDate=1518105600000, revisedDateStr=2018-02-09, acceptedDate=null, acceptedDateStr=null, onlineDate=1795005848109, onlineDateStr=2026-11-18, pubDate=1523289600000, pubDateStr=2018-04-10, doiRegisterDate=null, doiRegisterDateStr=null, onlineIssueDate=1795005848109, onlineIssueDateStr=2026-11-18, onlineJustAcceptDate=null, onlineJustAcceptDateStr=null, onlineFirstDate=null, onlineFirstDateStr=null, sourceXml=null, magXml=null, createTime=1795005848109, creator=13701087609, updateTime=1795005848109, updator=13701087609, issue=Issue{id=1329914129239879905, tenantId=1146029695717560320, journalId=1319690329412173987, year='2018', volume='39', issue='4', pageStart='217', pageEnd='288', issueExtLink='null', onlineDate='null', pubDate='1523289600000', pubDateStr='2018-04-10', beforeIssueId=null, nextIssueId=null, price=null, status=1, issueComplete=1, articleOrder=1, issueType=-1, specialIssue=null, createTime=1795005837020, creator='13701087609', updateTime=1795056585474, updator='13701087609', preIssue=null, nextIssue=null, articleTotal=null, ext={EN=IssueExt(id=1330126984102917093, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329914129239879905, language=EN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=), CN=IssueExt(id=1330126984102917094, tenantId=1146029695717560320, journalId=1319690329412173987, issueId=1329914129239879905, language=CN, specialIssueTitle=, coverIllustrator=null, specialIssueEditor=, specialIssueAbout=)}, issueFiles=null, downloadFileDto=null}, startPage=280, endPage=284, ext={EN=ArticleExt(id=1329914175951844144, articleId=1329914175750517551, tenantId=1146029695717560320, journalId=1319690329412173987, language=EN, title=Advances of rheumatoid arthritis treatment with adalimumab, columnId=1325221194584162830, journalTitle=World Clinical Drug, columnName=Review, runingTitle=null, highlight=null, articleAbstract=

Rheumatoid arthritis (RA) is an autoimmune disease characterized by symmetric poly arthritis as the main clinical manifestation. The biological agents in RA treatment have a certain effect. Recently, the clinical studies of adalimumab obtain much progresses, especially the drug withdrawal and reduction has been attended. This review describes the recent advances of adalimumab in RA treatment, and a brief overview of its safety.

, authors=Xia WANG, Guang-tao XIA*, authorsList=Xia WANG, Guang-tao XIA, authorCompany=null, correspAuthors=Guang-tao XIA, authorNote=null, correspAuthorsNote=null, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=null, magXml=null, pdfUrl=null, pdf=null, pdfFileSize=null, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=null, mapNumber=null, fund=null), CN=ArticleExt(id=1329914176186725169, articleId=1329914175750517551, tenantId=1146029695717560320, journalId=1319690329412173987, language=CN, title=阿达木单抗治疗类风湿关节炎的研究进展, columnId=1325221194743546384, journalTitle=世界临床药物, columnName=综述评论, runingTitle=null, highlight=null, articleAbstract=

类风湿关节炎(RA)是一种以对称性多关节炎为主要临床表现的自身免疫性疾病。生物制剂用于治疗RA具有一定疗效,近年来阿达木单抗临床研究获得一定进展,其停药和减量的相关报道也引起广泛关注。本文综述近年来阿达木单抗治疗RA的研究进展,及其停药和减量的报道,并简要概述其安全性。

, authors=王霞, 夏光涛*, authorsList=王霞, 夏光涛, authorCompany=null, correspAuthors=夏光涛, authorNote=

王霞,住院医师,研究方向为自身免疫病的诊治。

, correspAuthorsNote=
夏光涛,副主任医师,研究方向为自身免疫病的诊治。
, copyrightStatement=null, copyrightOwner=null, extLink=null, articleAbsUrl=null, sourceXml=zlEqiPA29kfGBQ5yzl784A==, magXml=QkOpMs0NPqBCX+cxD3Ms7Q==, pdfUrl=null, pdf=IV3QlubbYtbAI90CMh/jZA==, pdfFileSize=906379, pdfExtLink=null, richHtmlUrl=null, mobilePdfUrl=null, reviewReport=null, pdfFirstPage=null, abstractGraph=null, abstractGraphContent=null, abstractVideo=null, citation=null, cebUrl=null, magXmlContent=ZRZLDGkAiZ62FWHWvJhqfQ==, mapNumber=null, fund=null)}, authors=[Author(id=1329914176467743542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914176547435320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, authorId=1329914176467743542, language=EN, stringName=Xia WANG, firstName=Xia, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji'nan 250021, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914176601961273, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, authorId=1329914176467743542, language=CN, stringName=王霞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东大学附属省立医院风湿免疫科,济南 250021, bio={"content":"

王霞,住院医师,研究方向为自身免疫病的诊治。

"}, bioImg=null, bioContent=

王霞,住院医师,研究方向为自身免疫病的诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914176392246066, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, xref=null, ext=[AuthorCompanyExt(id=1329914176400634675, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, companyId=1329914176392246066, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji'nan 250021, China), AuthorCompanyExt(id=1329914176409023284, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, companyId=1329914176392246066, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学附属省立医院风湿免疫科,济南 250021)])]), Author(id=1329914176664875835, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914176727790397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, authorId=1329914176664875835, language=EN, stringName=Guang-tao XIA, firstName=Guang-tao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji'nan 250021, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914176786510654, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, authorId=1329914176664875835, language=CN, stringName=夏光涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=山东大学附属省立医院风湿免疫科,济南 250021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914176392246066, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, xref=null, ext=[AuthorCompanyExt(id=1329914176400634675, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, companyId=1329914176392246066, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji'nan 250021, China), AuthorCompanyExt(id=1329914176409023284, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, companyId=1329914176392246066, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学附属省立医院风湿免疫科,济南 250021)])])], keywords=[Keyword(id=1329914176870396735, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, language=EN, orderNo=1, keyword=adalimumab), Keyword(id=1329914176929116992, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, language=EN, orderNo=2, keyword=rheumatoid arthritis (RA)), Keyword(id=1329914176987837249, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, language=EN, orderNo=3, keyword=treatment), Keyword(id=1329914177059140418, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, language=EN, orderNo=4, keyword=safety evaluation), Keyword(id=1329914177117860675, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, language=CN, orderNo=1, keyword=阿达木单抗), Keyword(id=1329914177214329668, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, language=CN, orderNo=2, keyword=类风湿关节炎(RA)), Keyword(id=1329914177268855621, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, language=CN, orderNo=3, keyword=治疗), Keyword(id=1329914177327575878, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, language=CN, orderNo=4, keyword=安全性评价)], refs=[Reference(id=1329914177507930952, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[1], rfOrder=0, authorNames=null, journalName=null, refType=null, unstructuredReference=Desplat-Jégo S, Burkly L, Putterman C. Targeting TNF and its family members in autoimmune/inflammatory disease[J]. Mediators Inflamm, 2014, 628748. doi: 10.1155/2014/628748, articleTitle=null, refAbstract=null), Reference(id=1329914177587622729, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[2], rfOrder=1, authorNames=null, journalName=null, refType=null, unstructuredReference=Gravallese EM, Walsh NC. Rheumatoid arthritis: repair of erosion in RA--shifting the balance to formation[J]. Nat Rev Rheumatol, 2011, 7(11): 626-628., articleTitle=null, refAbstract=null), Reference(id=1329914177658925898, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[3], rfOrder=2, authorNames=null, journalName=null, refType=null, unstructuredReference=Mease PJ. Adalimumab in the treatment of arthritis[J]. Ther Clin Risk Manag, 2007, 3(1): 133-148., articleTitle=null, refAbstract=null), Reference(id=1329914177721840459, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[4], rfOrder=3, authorNames=null, journalName=null, refType=null, unstructuredReference=谢玉婷, 汪年松. 阿达木单抗在类风湿关节炎治疗中的应用[J]. 世界临床药物, 2012, 33(2): 65-69., articleTitle=null, refAbstract=null), Reference(id=1329914177780560716, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[5], rfOrder=4, authorNames=null, journalName=null, refType=null, unstructuredReference=Kavanaugh A, Fleischmann RM, Emery P, et al. Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study[J]. Ann Rheum Dis, 2013, 72(1): 64-71., articleTitle=null, refAbstract=null), Reference(id=1329914177856058189, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[6], rfOrder=5, authorNames=null, journalName=null, refType=null, unstructuredReference=Smolen JS, Emery P, Fleischmann R, et al. Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial[J]. Lancet, 2014, 383(9914): 321-332., articleTitle=null, refAbstract=null), Reference(id=1329914177927361358, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[7], rfOrder=6, authorNames=null, journalName=null, refType=null, unstructuredReference=Furst DE, Kavanaugh A, Florentinus S, et al. Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy.[J]. Rheumatology (Oxford), 2015, 54(12): 2188-2197., articleTitle=null, refAbstract=null), Reference(id=1329914178028024655, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[8], rfOrder=7, authorNames=null, journalName=null, refType=null, unstructuredReference=Keystone EC, Breedveld FC, van der Heijde D, et al. Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extension[J]. J Rheumatol, 2014, 41(1): 5-14., articleTitle=null, refAbstract=null), Reference(id=1329914178107716432, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[9], rfOrder=8, authorNames=null, journalName=null, refType=null, unstructuredReference=Detert J, Bastian H, Listing J, et al. Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study[J]. Ann Rheum Dis, 2013, 72(6): 844-850., articleTitle=null, refAbstract=null), Reference(id=1329914178187408209, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[10], rfOrder=9, authorNames=null, journalName=null, refType=null, unstructuredReference=Yamanaka H, Ishiguro N, Takeuchi T, et al. Recovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results of the HOPEFUL-1 trial[J]. Rheumatology (Oxford), 2014, 53(5): 904-913., articleTitle=null, refAbstract=null), Reference(id=1329914178267099986, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[11], rfOrder=10, authorNames=null, journalName=null, refType=null, unstructuredReference=Takeuchi T, Yamanaka H, Ishiguro N, et al. Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study[J]. Ann Rheum Dis, 2014, 73(3): 536-543., articleTitle=null, refAbstract=null), Reference(id=1329914178338403155, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[12], rfOrder=11, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanaka Y, Yamanaka H, Ishiguro N, et al. Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study[J]. RMD Open, 2016, 2(1): e000189., articleTitle=null, refAbstract=null), Reference(id=1329914178401317716, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[13], rfOrder=12, authorNames=null, journalName=null, refType=null, unstructuredReference=Tanaka Y, Hirata S, Kubo S, et al. Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study[J]. Ann Rheum Dis, 2015, 74(2): 389-395., articleTitle=null, refAbstract=null), Reference(id=1329914178476815189, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[14], rfOrder=13, authorNames=null, journalName=null, refType=null, unstructuredReference=Chang C, Chen K, Chen Y, et al. FRI0196 real-world impact of Taiwan health policy on dose tapering and withdrawing biologics in rheumatoid arthritis patients: a retrospective chart review study[J]. Ann Rheum Dis, 2016, 75(Suppl 2): S501-S502., articleTitle=null, refAbstract=null), Reference(id=1329914178531341142, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[15], rfOrder=14, authorNames=null, journalName=null, refType=null, unstructuredReference=Chatzidionysiou K, Turesson C, Teleman A, et al. A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission[J]. RMD Open, 2016, 2(1): e000133., articleTitle=null, refAbstract=null), Reference(id=1329914178602644311, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[16], rfOrder=15, authorNames=null, journalName=null, refType=null, unstructuredReference=Burmester GR, Landewé R, Genovese MC, et al. Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis[J]. Ann Rheum Dis, 2017, 76(2): 414-417., articleTitle=null, refAbstract=null), Reference(id=1329914178678141784, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[17], rfOrder=16, authorNames=null, journalName=null, refType=null, unstructuredReference=杨喜梅, 窦存瑞, 魏花萍. 阿达木单抗治疗对缓解抗风湿性药物无效的类风湿性关节炎的系统评价[J]. 中国循证医学杂志, 2011, 11(1): 84-90., articleTitle=null, refAbstract=null), Reference(id=1329914178762027865, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[18], rfOrder=17, authorNames=null, journalName=null, refType=null, unstructuredReference=Burmester GR, Panaccione R, Gordon KB, et al. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease[J]. Ann Rheum Dis, 2013, 72(4): 517-524., articleTitle=null, refAbstract=null), Reference(id=1329914178829136730, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, doi=null, pmid=null, pmcid=null, year=null, volume=null, issue=null, pageStart=null, pageEnd=null, url=null, language=null, rfNumber=[19], rfOrder=18, authorNames=null, journalName=null, refType=null, unstructuredReference=吴凡, 盛晓燕, 马凌悦, 等. 阿达木单抗治疗RA有效性和安全性的系统评价[J]. 中国临床药理学杂志, 2016, 32(6): 563-566., articleTitle=null, refAbstract=null)], funds=[Fund(id=1329914177419850567, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, awardId=ZR2015HM082, language=CN, fundingSource=山东省自然科学基金(ZR2015HM082), fundOrder=null, country=null)], companyList=[AuthorCompany(id=1329914176392246066, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, xref=null, ext=[AuthorCompanyExt(id=1329914176400634675, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, companyId=1329914176392246066, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji'nan 250021, China), AuthorCompanyExt(id=1329914176409023284, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, companyId=1329914176392246066, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学附属省立医院风湿免疫科,济南 250021)])], figs=null, attaches=null, journal=Journal(id=1319689997550452896, delFlag=0, nameCn=世界临床药物, nameEn=World Clinical Drug, nameHistory1=null, nameHistory2=null, issn=1672-9188, eissn=null, cn=31-1939/R, coden=SLYHAA, periodic=0, language=CN, oaType=null, ccby=null, superviseOffice=null, ownerOffice=null, pubOffice=null, editorOffice=null, officeType=null, aims=null, clcCode=null, officeProv=null, officeCity=null, officeAddr=null, officeZip=null, officeEmail=null, officePhone=null, editDirector=null, officeDirector=null, officeDirectorPhone=null, officeStaffNum=null, officeEmpNum=null, coverPicUrl=9c6IkcJKa1cF20h1u6lJeQ==, journalPrice=null, startedYear=null, abbrevIsoEn=World Clinical Drug, journalRemark=null, publicationField=null, createdTime=1792568214072, updatedTime=1792747519563, createdBy=18614031015, updatedBy=13701087609, firstLetterCn=S, firstLetterEn=S, subjectCode=Medical and Pharmaceutical Sciences, subjectName=null, subjectCodeEn=Medical and Pharmaceutical Sciences, subjectNameEn=null, picCn=9c6IkcJKa1cF20h1u6lJeQ==, picEn=MRqUlTwfL6oqIHNy7eyFZQ==, jcr=null, cjcr=null, exts=[JournalExt(id=1320442059660570919, language=CN, name=世界临床药物, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519650, updatedTime=1792747519650, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""}), JournalExt(id=1320442059723485480, language=EN, name=World Clinical Drug, nameHistory1=null, nameHistory2=null, managedBy=, sponsoredBy=, publishedBy=, editorOffice=, officeProv=null, officeCity=null, officeAddr=, officeZip=, editDirector=, officeDirector=null, officePhone=null, coverPicUrl=null, journalRemark=, submitArticleUrl=null, websiteUrl=, createdTime=1792747519665, updatedTime=1792747519665, createdBy=13701087609, updatedBy=13701087609, submissionGuidelinesUrl=, submissionAuthorUrl=http://www.jwph.com.cn/journalx_sjlcyw/authorLogOn.action, submissionEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorLogOn.action, submissionReviewUrl=http://www.jwph.com.cn/journalx_sjlcyw/expertLogOn.action, submissionCeEditorUrl=http://www.jwph.com.cn/journalx_sjlcyw/editorInChiefLogOn.action, submissionAeEditorUrl=, option={"copyright":""})], databaseList=null, tenantJournalId=1319690329412173987, websiteList=[Website(id=1321427104911179915, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/CN, language=CN, createTime=1792982372739, createBy=18614031015, updateTime=1792982514949, updateBy=18614031015, name=世界临床药物-中文, tplId=1146099689490845704, title=世界临床药物, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428428256031726, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=articleTextType, value=kx, createTime=1792982688249, updateTime=1792982688249, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428193117163, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982688234, updateTime=1792982688234, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428302169073, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=grayFlag, value=0, createTime=1792982688260, updateTime=1792982688260, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428172145642, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982688229, updateTime=1792982688229, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428327334899, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=minRunFlag, value=0, createTime=1792982688266, updateTime=1792982688266, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428226671597, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/file/pic, createTime=1792982688242, updateTime=1792982688242, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428314751986, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=silenceFlag, value=0, createTime=1792982688263, updateTime=1792982688263, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428209894380, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_cn_619/, createTime=1792982688238, updateTime=1792982688238, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428268614639, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeColor, value=null, createTime=1792982688252, updateTime=1792982688252, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428428289586160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104911179915, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982688257, updateTime=1792982688257, creator=18614031015, updator=18614031015)]), Website(id=1321427104990871693, webName=null, webTitle=null, webDomain=null, webCopyrigh=null, webIpcNo=null, seoTitle=null, seoKeywords=null, seoDescription=null, tenantJournalId=null, journalId=1319690329412173987, journalNameCn=null, journalNameEn=null, grayFlag=null, tenantId=1146029695717560320, platformId=null, journalGroupId=null, journalGroupNameCn=null, journalGroupNameEn=null, type=1, domain=https://castjournals.cast.org.cn/joweb/sjlcyw/EN, language=EN, createTime=1792982372758, createBy=18614031015, updateTime=1792982556355, updateBy=18614031015, name=世界临床药物-英文, tplId=1146101810881728533, title=World Clinical Drug, delFlag=0, indexPage=/home, props=[WebsiteProps(id=1321428446820021244, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=articleTextType, value=kx, createTime=1792982692675, updateTime=1792982692675, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446757106681, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=banner, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=RR/csUBcM48ejcuaaK5s0g==, createTime=1792982692660, updateTime=1792982692660, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447109428223, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=grayFlag, value=0, createTime=1792982692744, updateTime=1792982692744, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446736135160, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=logo, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic?fileId=yyY2emcxcV1CfIeK9tH8ZA==, createTime=1792982692655, updateTime=1792982692655, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447142981632, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=minRunFlag, value=0, createTime=1792982692752, updateTime=1792982692752, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446790661115, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=picServerUrl, value=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/file/pic, createTime=1792982692668, updateTime=1792982692668, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447130399745, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=silenceFlag, value=0, createTime=1792982692749, updateTime=1792982692749, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446769689594, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=staticResourcePath, value=https://castjournals.cast.org.cn/joweb/cast_kjdb_en_623/, createTime=1792982692663, updateTime=1792982692663, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428446832604157, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeColor, value=null, createTime=1792982692678, updateTime=1792982692678, creator=18614031015, updator=18614031015), WebsiteProps(id=1321428447092651006, tenantId=1146029695717560320, journalId=null, journalGroupId=null, siteId=1321427104990871693, code=themeStyle, value=.style-1 .main-menu ul>li { margin-right: 18px; } @media (max-width: 1442px) { .style-1 .main-menu ul>li a { font-size: 16px; padding: 10px 0; } }, createTime=1792982692740, updateTime=1792982692740, creator=18614031015, updator=18614031015)])], journalTitle=世界临床药物, weixinUrl=null, journalUrl=http://www.jwph.com.cn/, iacademicId=null, status=1, seqNo=null, journalTitleEn=World Clinical Drug, journalPhotoCn=9c6IkcJKa1cF20h1u6lJeQ==, journalPhotoEn=MRqUlTwfL6oqIHNy7eyFZQ==, journalFirstLetter=S, journalRecommend=null, journalNew=null, journalCollection=null, jcrJf=null, cjcrJf=null, jcrJfStr=null, cjcrJfStr=null, submissionFirstDecision=null, sciSubjectClassification=null, casSubjectClassification=null, citeScore=null, totalCitationFrequency=null, icpCode=null, psCode=null, advertisingLicenseCode=null, copyrightInformation=null, country=null, option=, provinceCode=null, provinceName=null, collectFlag=false, interPubPlatform=, interPubPlatformUrl=null), detailUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.04.012, detailUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2018.04.012, pdfUrlCn=https://castjournals.cast.org.cn/joweb/sjlcyw/CN/PDF/10.13683/j.wph.2018.04.012, pdfUrlEn=https://castjournals.cast.org.cn/joweb/sjlcyw/EN/PDF/10.13683/j.wph.2018.04.012, aliStartDate=0, aliEndDate=0, collectionFlag=false, citedCount=null, citedUrl=null, previewStatus=0, delFlag=0, hasFullText=0, orderTime=1523289600000, fullTextJson=null, articleText=null, reference=null)
收藏切换
阿达木单抗治疗类风湿关节炎的研究进展
王霞 , 夏光涛 *
世界临床药物 | 综述评论 2018,39(4): 280-284
收起
收藏切换
世界临床药物 |综述评论 2018 , 39 (4) : 280 -284
阿达木单抗治疗类风湿关节炎的研究进展
全屏
[Author(id=1329914176467743542, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, orderNo=0, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=0, authorType=1, ext={EN=AuthorExt(id=1329914176547435320, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, authorId=1329914176467743542, language=EN, stringName=Xia WANG, firstName=Xia, middleName=null, lastName=WANG, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji'nan 250021, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914176601961273, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, authorId=1329914176467743542, language=CN, stringName=王霞, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=null, address=山东大学附属省立医院风湿免疫科,济南 250021, bio={"content":"

王霞,住院医师,研究方向为自身免疫病的诊治。

"}, bioImg=null, bioContent=

王霞,住院医师,研究方向为自身免疫病的诊治。

, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914176392246066, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, xref=null, ext=[AuthorCompanyExt(id=1329914176400634675, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, companyId=1329914176392246066, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji'nan 250021, China), AuthorCompanyExt(id=1329914176409023284, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, companyId=1329914176392246066, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学附属省立医院风湿免疫科,济南 250021)])]), Author(id=1329914176664875835, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, orderNo=1, firstName=null, middleName=null, lastName=null, nameCn=null, orcid=null, stid=null, country=null, authorPic=null, dead=0, email=null, emailSecond=null, emailThird=null, correspondingAuthor=1, authorType=1, ext={EN=AuthorExt(id=1329914176727790397, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, authorId=1329914176664875835, language=EN, stringName=Guang-tao XIA, firstName=Guang-tao, middleName=null, lastName=XIA, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji'nan 250021, China, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null), CN=AuthorExt(id=1329914176786510654, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, authorId=1329914176664875835, language=CN, stringName=夏光涛, firstName=null, middleName=null, lastName=null, prefix=null, suffix=null, authorComment=null, nameInitials=null, affiliation=null, department=null, xref=*, address=山东大学附属省立医院风湿免疫科,济南 250021, bio=null, bioImg=null, bioContent=null, aboutCorrespAuthor=null)}, companyList=[AuthorCompany(id=1329914176392246066, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, xref=null, ext=[AuthorCompanyExt(id=1329914176400634675, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, companyId=1329914176392246066, language=EN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji'nan 250021, China), AuthorCompanyExt(id=1329914176409023284, tenantId=1146029695717560320, journalId=1319690329412173987, articleId=1329914175750517551, companyId=1329914176392246066, language=CN, country=null, province=null, city=null, postcode=null, companyName=null, departmentName=null, remark=山东大学附属省立医院风湿免疫科,济南 250021)])])]
王霞, 夏光涛*
作者信息
  • 山东大学附属省立医院风湿免疫科,济南 250021
通讯作者:
夏光涛,副主任医师,研究方向为自身免疫病的诊治。
作者简介:

王霞,住院医师,研究方向为自身免疫病的诊治。

Advances of rheumatoid arthritis treatment with adalimumab
Xia WANG, Guang-tao XIA*
Affiliations
  • Department of Rheumatology and Immunology, Shandong Provincial Hospital, Shandong University, Ji'nan 250021, China
出版时间: 2018-04-10 doi: 10.13683/j.wph.2018.04.012
文章导航
收藏切换

类风湿关节炎(RA)是一种以对称性多关节炎为主要临床表现的自身免疫性疾病。生物制剂用于治疗RA具有一定疗效,近年来阿达木单抗临床研究获得一定进展,其停药和减量的相关报道也引起广泛关注。本文综述近年来阿达木单抗治疗RA的研究进展,及其停药和减量的报道,并简要概述其安全性。

阿达木单抗  /  类风湿关节炎(RA)  /  治疗  /  安全性评价

Rheumatoid arthritis (RA) is an autoimmune disease characterized by symmetric poly arthritis as the main clinical manifestation. The biological agents in RA treatment have a certain effect. Recently, the clinical studies of adalimumab obtain much progresses, especially the drug withdrawal and reduction has been attended. This review describes the recent advances of adalimumab in RA treatment, and a brief overview of its safety.

adalimumab  /  rheumatoid arthritis (RA)  /  treatment  /  safety evaluation
王霞, 夏光涛. 阿达木单抗治疗类风湿关节炎的研究进展. 世界临床药物, 2018 , 39 (4) : 280 -284 . DOI: 10.13683/j.wph.2018.04.012
Xia WANG, Guang-tao XIA. Advances of rheumatoid arthritis treatment with adalimumab[J]. World Clinical Drug, 2018 , 39 (4) : 280 -284 . DOI: 10.13683/j.wph.2018.04.012
  • 山东省自然科学基金(ZR2015HM082)
参考文献 引证文献
排序方式:
[1]
Desplat-Jégo S, Burkly L, Putterman C. Targeting TNF and its family members in autoimmune/inflammatory disease[J]. Mediators Inflamm, 2014, 628748. doi: 10.1155/2014/628748
[2]
Gravallese EM, Walsh NC. Rheumatoid arthritis: repair of erosion in RA--shifting the balance to formation[J]. Nat Rev Rheumatol, 2011, 7(11): 626-628.
[3]
Mease PJ. Adalimumab in the treatment of arthritis[J]. Ther Clin Risk Manag, 2007, 3(1): 133-148.
[4]
谢玉婷, 汪年松. 阿达木单抗在类风湿关节炎治疗中的应用[J]. 世界临床药物, 2012, 33(2): 65-69.
[5]
Kavanaugh A, Fleischmann RM, Emery P, et al. Clinical, functional and radiographic consequences of achieving stable low disease activity and remission with adalimumab plus methotrexate or methotrexate alone in early rheumatoid arthritis: 26-week results from the randomised, controlled OPTIMA study[J]. Ann Rheum Dis, 2013, 72(1): 64-71.
[6]
Smolen JS, Emery P, Fleischmann R, et al. Adjustment of therapy in rheumatoid arthritis on the basis of achievement of stable low disease activity with adalimumab plus methotrexate or methotrexate alone: the randomised controlled OPTIMA trial[J]. Lancet, 2014, 383(9914): 321-332.
[7]
Furst DE, Kavanaugh A, Florentinus S, et al. Final 10-year effectiveness and safety results from study DE020: adalimumab treatment in patients with rheumatoid arthritis and an inadequate response to standard therapy.[J]. Rheumatology (Oxford), 2015, 54(12): 2188-2197.
[8]
Keystone EC, Breedveld FC, van der Heijde D, et al. Longterm effect of delaying combination therapy with tumor necrosis factor inhibitor in patients with aggressive early rheumatoid arthritis: 10-year efficacy and safety of adalimumab from the randomized controlled PREMIER trial with open-label extension[J]. J Rheumatol, 2014, 41(1): 5-14.
[9]
Detert J, Bastian H, Listing J, et al. Induction therapy with adalimumab plus methotrexate for 24 weeks followed by methotrexate monotherapy up to week 48 versus methotrexate therapy alone for DMARD-naive patients with early rheumatoid arthritis: HIT HARD, an investigator-initiated study[J]. Ann Rheum Dis, 2013, 72(6): 844-850.
[10]
Yamanaka H, Ishiguro N, Takeuchi T, et al. Recovery of clinical but not radiographic outcomes by the delayed addition of adalimumab to methotrexate-treated Japanese patients with early rheumatoid arthritis: 52-week results of the HOPEFUL-1 trial[J]. Rheumatology (Oxford), 2014, 53(5): 904-913.
[11]
Takeuchi T, Yamanaka H, Ishiguro N, et al. Adalimumab, a human anti-TNF monoclonal antibody, outcome study for the prevention of joint damage in Japanese patients with early rheumatoid arthritis: the HOPEFUL 1 study[J]. Ann Rheum Dis, 2014, 73(3): 536-543.
[12]
Tanaka Y, Yamanaka H, Ishiguro N, et al. Adalimumab discontinuation in patients with early rheumatoid arthritis who were initially treated with methotrexate alone or in combination with adalimumab: 1 year outcomes of the HOPEFUL-2 study[J]. RMD Open, 2016, 2(1): e000189.
[13]
Tanaka Y, Hirata S, Kubo S, et al. Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study[J]. Ann Rheum Dis, 2015, 74(2): 389-395.
[14]
Chang C, Chen K, Chen Y, et al. FRI0196 real-world impact of Taiwan health policy on dose tapering and withdrawing biologics in rheumatoid arthritis patients: a retrospective chart review study[J]. Ann Rheum Dis, 2016, 75(Suppl 2): S501-S502.
[15]
Chatzidionysiou K, Turesson C, Teleman A, et al. A multicentre, randomised, controlled, open-label pilot study on the feasibility of discontinuation of adalimumab in established patients with rheumatoid arthritis in stable clinical remission[J]. RMD Open, 2016, 2(1): e000133.
[16]
Burmester GR, Landewé R, Genovese MC, et al. Adalimumab long-term safety: infections, vaccination response and pregnancy outcomes in patients with rheumatoid arthritis[J]. Ann Rheum Dis, 2017, 76(2): 414-417.
[17]
杨喜梅, 窦存瑞, 魏花萍. 阿达木单抗治疗对缓解抗风湿性药物无效的类风湿性关节炎的系统评价[J]. 中国循证医学杂志, 2011, 11(1): 84-90.
[18]
Burmester GR, Panaccione R, Gordon KB, et al. Adalimumab: long-term safety in 23 458 patients from global clinical trials in rheumatoid arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, psoriatic arthritis, psoriasis and Crohn's disease[J]. Ann Rheum Dis, 2013, 72(4): 517-524.
[19]
吴凡, 盛晓燕, 马凌悦, 等. 阿达木单抗治疗RA有效性和安全性的系统评价[J]. 中国临床药理学杂志, 2016, 32(6): 563-566.
2018年第39卷第4期
17
4
0
引用本文
BibTeX
文章信息
doi: 10.13683/j.wph.2018.04.012
  • 接收时间:2018-01-18
  • 首发时间:2026-11-18
  • 出版时间:2018-04-10
补充材料
相关文章
文章信息
作者
出版历史
  • 收稿日期:2018-01-18
  • 修回日期:2018-02-09
基金
山东省自然科学基金(ZR2015HM082)
作者信息
    山东大学附属省立医院风湿免疫科,济南 250021

通讯作者:

夏光涛,副主任医师,研究方向为自身免疫病的诊治。
参考文献
分享链接
https://castjournals.cast.org.cn/joweb/sjlcyw/CN/10.13683/j.wph.2018.04.012
分享至
全文二维码

扫描看全文

引用本文
BibTeX
本文的引用情况
2种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏